Coegin Pharma AbNGM: COEGIN

COEGIN: Follicopeptide launch on track, with improved Q1 results and strong market positioning

· Issued by Coegin Pharma AB

Coegin Pharma advanced Follicopeptide launch preparations, improved operating results, and maintained a strong equity ratio, while focusing on international partnerships and cost efficiency. The company targets major growth in the hair growth and skin pigmentation markets.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Coegin Pharma Ab

All Coegin Pharma Ab news releases